POINT Biopharma Global Inc.

08/08/2022 | Press release | Distributed by Public on 08/08/2022 18:41

POINT Biopharma to Host Investor Education Event, “Understanding the PNT2002 Phase 3 SPLASH Trial Control Arm”, on August 18, 2022